Hims stock plummeted late Thursday after Food and Drug Administration Commissioner Marty Makary said the agency will target "mass-marketing" of "illegal copycat drugs." The news comes just after after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results